Panacea Life Sciences Holdings, Inc. (PLSH): Cash & Equivalents
Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$100.9K
As of 2023-12-31
+6.1%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $100.9K | n/m | 2024-04-01, Balance as of period end |
| 2022-12-31 | $7.0K | -64.8% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $19.8K | -76.6% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $84.4K | +358.5% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $18.4K | +839.0% | 2021-04-23, Balance as of period end |
| 2018-12-31 | $2.0K | -98.8% | 2020-05-22, Balance as of period end |
| 2017-12-31 | $161.2K | -84.7% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $1.06M | n/a | 2018-04-02, Balance as of period end |
| 2015-12-31 | $0 | -100.0% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $41.7K | n/a | 2016-02-29, Balance as of period end |